RebelEM
MAY 25, 2023
I recently gave a talk on the initial management of trauma patients with hemorrhagic shock. Clinical Take Home Point: In patients with TBI and hypovolemic shock, target a SBP or MAP ≥90mmHg, but know this is based on limited evidence. vs SBP target <90mmHg which resulted in a mortality of 33.4%
ALiEM
JUNE 5, 2023
Glucocorticoid therapy should be considered in anthrax meningitis, cutaneous anthrax with extensive tissue edema involving the head and neck, or anthrax with vasopressor-resistant shock [9]. When should you administer post-exposure prophylaxis (PEP)? 6,10] PEP is unlikely to be indicated for naturally occurring cutaneous anthrax.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
ETM Course
JUNE 28, 2015
This is a potentially lifesaving treatment pioneered by the US military 1 for patients with exsanguinating pelvic and lower limb haemorrhage. Resuscitative endovascular balloon occlusion of the aorta (REBOA) as an adjunct for hemorrhagic shock. Shock 2014; 41(2): 130–7 12. 2011 Dec;71(6):1869-72 (full article free text) 2.
ETM Course
MAY 3, 2017
Based on reasonable quality data from recent military (and some civilian) studies, tourniquet use for the arrest of life-threatening haemorrhage from exsanguinating limb trauma is now being advocated. This post provides some general and specific information and practical tips on tourniquet use. When should I use a tourniquet?
Critical Care Now
JULY 7, 2024
Military practice guidelines, along with ACEP and the American College of Surgeons, recommend REBOA for traumatic life-threatening hemorrhage below the diaphragm in patients with hemorrhagic shock who are unresponsive or transiently responsive to resuscitation.
Sensible Medicine
SEPTEMBER 3, 2024
We want a resort that runs with military precision, especially the plumbing. ” It shocked his teacher when he wrote his name in magnet letters after a week of taking lithium. But these are not FDA approved treatments and the logistics are horrible and spectacular. I hope by 2026, the gene therapy market will be more mature.
RebelEM
NOVEMBER 20, 2023
Military practice guidelines recommend REBOA for profound shock (SBP <90mmHg) 1 and ACEP along with the American College of surgeons recommend REBOA for traumatic life-threatening hemorrhage below the diaphragm in patients with hemorrhagic shock who are unresponsive or transiently responsive to resuscitation.
Expert insights. Personalized for you.
145 
Let's personalize your content